期刊的影响因子--文章列表

期刊文章列表
Keliang Chen¹，Tao Wang²，Yong Li¹，Jun Wu¹，Cheng-Xiao Zhao¹，Sheng Liu¹，Fengrun Sun²，Yehong Fang²，Jiahuan Hu¹，Jinping Hu¹，Chong-Jing Zhang¹，Haibo Yu¹，Chao Ma²，Shi-Shan Yu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Institute of Basic Medical Sciences，Neuroscience Center，Chinese Academy of Medical Sciences，Department of Human Anatomy，Histology and Embryology，School of Basic Medicine，Peking Union Medical College）.Rhodojaponin Ⅵ indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain[J].Acta Pharmaceutica Sinica B,2023,第3期 Xueqin Huang，Bingbing Sheng，Hemi Tian，Qiuxia Chen，Yingqi Yang，Brian Bui²，Jiang Pi³，Huaihong Cai³，Shanze Chen，Jianglin Zhang，Wei Chen²，Haibo Zhou，Pinghua Sun（The Second Clinical Medical College (Shenzhen People’s Hospital)，College of Pharmacy，Jinan University；Department of Physics，the University of Texas at Arlington；Department of Chemistry，Jinan University）.Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Qunjie Bi¹，Xu Song²，Yangyang Zhao¹，Xueyi Hu¹，Huan Yang¹，Rongrong Jin¹，Yu Nie¹（National Engineering Research Center for Biomaterials，College of Biomedical Engineering，Sichuan University；NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial & Institute of Regulatory Science for Medical Devices & NMPA Research Base of Regulatory Science for Medical Devices，Sichuan University）.Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses[J].Acta Pharmaceutica Sinica B,2023,第3期 Xin Jin^1,2,3，Shuai Wang^1,2，Limin Zhao^1,2,3，Wenjuan Huang^1,2，Yinxiang Zhang^1,2，Christophe Pannecouque⁴，Erik De Clercq⁴，Ge Meng^1,2，Huri Piao³，Fener Chen^1,2,3（Engineering Center of Catalysis and Synthesis for Chiral Molecules，Department of Chemistry，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs；Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules，Ministry of Education，College of Pharmacy，Yanbian University；Rega Institute for Medical Research，KU Leuven）.Development of fluorine-substituted NH₂-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors：Boosting the safety and metabolic stability[J].Acta Pharmaceutica Sinica B,2023,第3期 Mengyao Hao¹，Rong Fu¹，Jun Tai，Zhenhuan Tian³，Xia Yuan⁴，Yang Chen⁵，Mingjin Wang¹，Huimin Jiang¹，Ming Ji¹，Fangfang Lai¹，Nina Xue¹，Liping Bai⁶，Yizhun Zhu⁶，Xiaoxi Lv¹，Xiaoguang Chen¹，Jing Jin¹（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences，Peking Union Medical College；Department of Otolaryngology，Head and Neck Surgery，Children’s Hospital Capital Institute of Pediatrics；Department of Thoracic Surgery，Peking Union Medical College Hospital，Peking Union Medical College；State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Pharmacology，School of Pharmaceutical，Guangzhou University of Chinese Medicine；State Key Laboratory of Quality Research in Chinese Medicine，Macau Institute for Applied Research in Medicine and Health，Macau University of Science and Technology）.S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung[J].Acta Pharmaceutica Sinica B,2023,第3期 Zheng Zhou，Keying Li，Yongchao Chu，Chao Li，Tongyu Zhang，Peixin Liu，Tao Sun，Chen Jiang（Department of Pharmaceutics，School of Pharmacy，Fudan University，Key Laboratory of Smart Drug Delivery，Ministry of Education，State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science）.ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Sae-Bom Yoon^1,2，Hyowon Hong¹，Hee-Jong Lim¹，Ji Hye Choi¹，Yoon Pyo Choi³，Seong Wook Seo³，Hyuk Woo Lee³，Chong Hak Chae¹，Woo-Kyu Park¹，Hyun Young Kim¹，Daeyoung Jeong¹，Tran Quang De¹，Chang-Seon Myung²，Heeyeong Cho¹（Therapeutics & Biotechnology Division，Korea Research Institute of Chemical Technology；Department of Pharmacology，Chungnam National University College of Pharmacy；Future Medicine Co.Ltd.Rm616 LH-Business Growth Center）.A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Xiaoli Wei¹，Fan Yin^2,3，Miaomiao Wu^1,3，Qianqian Xie^3,4，Xueqin Zhao^3,4，Cheng Zhu¹，Ruiqian Xie^3,4，Chongqing Chen^3,4，Menghua Liu^3,4，Xueying Wang¹，Ruixue Ren¹，Guijie Kang^3,4，Chenwen Zhu¹，Jingjing Cong^3,4，Hua Wang^1,4，Xuefu Wang^3,4（Department of Oncology，the First Affiliated Hospital of Anhui Medical University；Department of Pharmacy，Huainan First People's Hospital，the First Affiliated Hospital of Anhui University of Science and Technology；School of Pharmacy，Anhui Medical University；Inflammation and Immune Mediated Diseases Laboratory of Anhui Province，Anhui Medical University）.G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes[J].Acta Pharmaceutica Sinica B,2023,第3期 Ling-Ling Wu^1,2,3，Qinxin Zhao^1,2,3，Qinghua Wang¹，Qingyang Zhang¹，Feiya Yang^2,3，Bo Zheng⁴，Hai-Yu Hu¹，Nianzeng Xing^2,3,5（State Key Laboratory of Bioactive Substances and Function of Natural Medicine，Institute of Materia Medica，Peking Union Medical College and Chinese Academy of Medical Sciences；Department of Urology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Pathology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Urology，Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital，Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University）.Membrane dual-targeting probes：A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection[J].Acta Pharmaceutica Sinica B,2023,第3期 Shiyang Shen，Teng Li，Jinyi Fan，Quanlin Shao，He Dong，Xiao Xu，Ran Mo（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases，Center of Advanced Pharmaceuticals and Biomaterials，School of Life Science and Technology，China Pharmaceutical University）.Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor[J].Acta Pharmaceutica Sinica B,2023,第3期 Xingcai Zhang¹，Luo Hai²，Yibo Gao^2,3,4,5，Guocan Yu⁶，Yingli Sun^3,7,8（School of Engineering and Applied Sciences，Harvard University；Central Laboratory，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Thoracic Surgery，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Laboratory of Translational Medicine，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology，Department of Chemistry，Tsinghua University；University of Chinese Academy of Sciences；CAS Key Laboratory of Genome Sciences and Information，Beijing Institute of Genomics，Chinese Academy of Sciences/China National Center for Bioinformation）.Lipid nanomaterials-based RNA therapy and cancer treatment[J].Acta Pharmaceutica Sinica B,2023,第3期 Juanjuan Feng^1,2，Zhengke Lian¹，Xinting Xia¹，Yue Lu¹，Kewen Hu³，Yunpeng Zhang¹，Yanan Liu¹，Longmiao Hu¹，Kun Yuan¹，Zhenliang Sun²，Xiufeng Pang¹（Shanghai Key Laboratory of Regulatory Biology，School of Life Sciences，East China Normal University；Joint Center for Translational Medicine，Southern Medical University Affiliated Fengxian Hospital；Cancer Institute，Fudan University Shanghai Cancer Center，Department of Oncology，Shanghai Medical College，Fudan University）.Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer[J].Acta Pharmaceutica Sinica B,2023,第3期 Jiang Wu¹，Wenfeng Gou²，Zhiyun Wang³，Huajie Chang³，Deguan Li²，Wenbin Hou²，Changxiao Liu⁴（Department of Pharmaceutical Engineering，School of Chemical Engineering and Technology，Tianjin University；Institute of Radiation Medicine，Chinese Academy of Medical Sciences；School of Chinese Materia Medica，Tianjin University of Traditional Chinese Medicine；Research Center for New Drug Evaluation，the State Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research）.Discovery of the radio-protecting effect of Ecliptae Herba,its constituents and targeting p53-mediated apoptosis in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第3期 Tengjie Yu¹，Zhihao Zhou¹，Shijia Liu²，Changjian Li¹，Zhi-Wei Zhang³，Yong Zhang³，Wei Jin¹，Keanqi Liu¹，Shuying Mao¹，Lei Zhu²，Lin Xie¹，Guangji Wang¹，Yan Liang¹（Key Lab of Drug Metabolism & Pharmacokinetics，State Key Laboratory of Natural Medicines，China Pharmaceutical University；Affliated Hospital of Nanjing University of Chinese Medicine；College of Chemical & Pharmaceutical Engineering，Hebei University of Science & Technology）.The role of phosphatidylcholine 34：1 in the occurrence,development and treatment of ulcerative colitis[J].Acta Pharmaceutica Sinica B,2023,第3期 Lu Zhang¹，Xiaolei Zhou²，Bowen Liu³，Xuhe Shi¹，Xianmeng Li¹，Feifei Xu¹，Xueli Fu¹，Xue Wang¹，Kai Ye¹，Tianzhi Jin¹，Huimin Sun¹，Qianqian Li¹，Weiying Zhang¹，Lihong Ye¹（State Key Laboratory of Medicinal Chemical Biology，Tianjin Key Laboratory of Protein Sciences，Department of Biochemistry and Molecular Biology，College of Life Sciences，Nankai University；College of Food Science & Biology，Hebei University of Science and Technology；Henan Key Laboratory of Immunology and Targeted Drugs，School of Laboratory Medicine，Xinxiang Medical University）.HBXIP blocks myosin-ⅡA assembly by phosphorylating and interacting with NMHC-ⅡA in breast cancer metastasis[J].Acta Pharmaceutica Sinica B,2023,第3期 Ning Shao¹，Xueyang Ma²，Ying-Ying Zhang¹，Donghui Yang²，Ming Ma²，Gong-Li Tang^1,3（State Key Laboratory of Bioorganic and Natural Products Chemistry，Center for Excellence in Molecular Synthesis，Shanghai Institute of Organic Chemistry，University of Chinese Academy of Sciences，Chinese Academy of Sciences；State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；School of Chemistry and Materials Science Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences）.Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis[J].Acta Pharmaceutica Sinica B,2023,第3期 Geni Ye，Maohua Huang，Yong Li，Jie Ouyang，Minfeng Chen，Qing Weng，Xiaobo Li，Huhu Zeng，Pei Long，Zepei Fan，Junqiang Yin，Wencai Ye，Dongmei Zhang（College of Pharmacy；Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research；Integrated Chinese and Western Medicine Postdoctoral Research Station；Department of Musculoskeletal Oncology）.Author correction to“The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway”[Acta Pharm Sin B 12(2022)1288–1304][J].药学学报(英文版),2023,第3期 Huaqing Zheng，Xiaolong Li，Xin Zeng，Chengcui Huang，Mingming Ma，Xiaofei Lv，Yajuan Zhang，Lu Sun，Guanlei Wang，Yanhua Du，Yongyuan Guan（Department of Pharmacology）.Author correction to“TMEM16A inhibits angiotensin Ⅱ-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner”[Acta Pharm Sin B 11(12)(2021)3994–4007][J].药学学报(英文版),2023,第3期（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2023,第3期 Chen Fu^1,2，Lifeng Yu¹，Yuxi Miao^1,2,3，Xinli Liu⁴，Zhaojin Yu^1,2，Minjie Wei^1,2,3（Department of Pharmacology，School of Pharmacy，China Medical University；Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation，China Medical University；Liaoning Medical Diagnosis and Treatment Center；Department of Digestive Oncology，Cancer Hospital of China Medical University，Liaoning Cancer Hospital&Institute）.Peptide-drug conjugates（PDCs）：a novel trend of research and development on targeted therapy, hype or hope?[J].Acta Pharmaceutica Sinica B,2023,第2期 Yeuan Ting Lee，Yi Jer Tan，Chern Ein Oon（Institute for Research in Molecular Medicine （INFORMM），Universiti Sains Malaysia）.Benzimidazole and its derivatives as cancer therapeutics：The potential role from traditional to precision medicine[J].Acta Pharmaceutica Sinica B,2023,第2期 Yujun Zhou¹，Jingshu Tang¹，Jiaqi Lan¹，Yong Zhang¹，Hongyue Wang¹，Qiuyu Chen¹，Yuying Kang¹，Yang Sun²，Xinhong Feng³，Lei Wu¹，Hongtao Jin^4,5，Shizhong Chen²，Ying Peng¹（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences&Peking Union Medical College；Department of Natural Medicines，School of Pharmaceutical Sciences，Peking University；Department of Neurology，Beijing Tsinghua Changgung Hospital，School of Clinical Medicine，Tsinghua University；New Drug Safety Evaluation Center，Institute of Materia Medica，Chinese Academy of Medical Sciences&Peking Union Medical College；NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug）.Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis[J].Acta Pharmaceutica Sinica B,2023,第2期 Haowen Xu^1,2，Jiahao Chen¹，Pan Chen¹，Weifeng Li¹，Jingjing Shao^1,2，Shanshan Hong¹，Yi Wang¹，Lingfeng Chen²，Wu Luo^1,3，Guang Liang^1,2（Chemical Biology Research Center，School of Pharmaceutical Sciences，Wenzhou Medical University；School of Pharmaceutical Sciences，Hangzhou Medical College；Medical Research Center，the First Affiliated Hospital of Wenzhou Medical University）.Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases[J].Acta Pharmaceutica Sinica B,2023,第2期 Ze Mi¹，Qing Yao^1,2,3，Yan Qi²，Jinhai Zheng⁴，Jiahao Liu¹，Zhenguo Liu¹，Hongpei Tan¹，Xiaoqian Ma¹，Wenhu Zhou^1,5,6，Pengfei Rong^1,6（Department of Radiology，The Third Xiangya Hospital，Central South University；Department of Pathology，Shihezi University School of Medicine and the First Affiliated Hospital to Shihezi University School of Medicine；Department of Pathology，Cangzhou Central Hospital&the Affiliated to Hebei Medical University；School of Biomedical Sciences，Hunan University；Xiangya School of Pharmaceutical Sciences，Central South University；Key Laboratory of Biological Nanotechnology of National Health Commission）.Salmonella-mediated blood-brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy[J].Acta Pharmaceutica Sinica B,2023,第2期 Jianjun Cheng^1,2,3，Haitian Zhao^1,4,5，Bin Li⁶，Hua Zhang²，Qianyu Zhao^1,2，Shiyao Fu^1,2，Ying Han^1,2，Weihong Lu^1,4,5，Jiahua Shi³，Xin Yang^1,2,4,5（School of Medicine and Health，Harbin Institute of Technology；School of Chemistry and Chemical Engineering，Harbin Institute of Technology；Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province，Henan University；Chongqing Research Institute，Harbin Institute of Technology；National and Local Joint Engineering Laboratory for Synthesis，Transformation and Separation of Extreme Environmental Nutrients；Academician Workstation，Jiangxi University of Chinese Medicine）.Photosensitive pro-drug nanoassemblies harboring a chemotherapeutic dormancy function potentiates cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第2期 Qianhua Feng^1,2，Yutong Hao¹，Shuaiqi Yang¹，Xiaomin Yuan¹，Jing Chen¹，Yuying Mei¹，Lanlan Liu³，Junbiao Chang^2,4，Zhenzhong Zhang^1,2，Lei Wang^1,2（School of Pharmaceutical Sciences，Zhengzhou University；Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases；Department of Pharmacy，The Third Affiliated Hospital of Zhengzhou University；College of Chemistry，Zhengzhou University）.A metabolic intervention strategy to break evolutionary adaptability of tumor for reinforced immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第2期 Shuang Cui，Huijian Hu，An Chen，Ming Cui，Xiaojie Pan，Pengfei Zhang，Guangji Wang，Hong Wang，Haiping Hao（State Key Laboratory of Natural Medicines，Key Laboratory of Drug Metabolism＆Pharmacokinetics，China Pharmaceutical University）.SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR[J].Acta Pharmaceutica Sinica B,2023,第2期 Dayuan Wang¹，Xiao Gu¹，Xinyi Ma¹，Jun Chen²，Qizhi Zhang²，Zhihua Yu¹，Juan Li¹，Meng Hu¹，Xiaofang Tan¹，Yuyun Tang¹，Jianrong Xu^1,3，Minjun Xu²，Qingxiang Song¹，Huahua Song¹，Gan Jiang¹，Zaiming Tang⁴，Xiaoling Gao¹，Hongzhuan Chen^1,3（Department of Pharmacology and Chemical Biology，State Key Laboratory of Oncogenes and Related Genes，Shanghai Universities Collaborative Innovation Center for Translational Medicine，Shanghai Jiao Tong University School of Medicine；Key Laboratory of Smart Drug Delivery，Ministry of Education，School of Pharmacy，Fudan University；Shanghai Frontiers Science Center of TCM Chemical Biology，Institute of Interdisciplinary Integrative Medicine Research，Shanghai University of Traditional Chinese Medicine；Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education，Shanghai Jiao Tong University School of Medicine）.Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming[J].Acta Pharmaceutica Sinica B,2023,第2期 Nazi Song¹，Hongjiao Xu¹，Shuohan Wu¹，Suijia Luo²，Jingyao Xu¹，Qian Zhao¹，Rui Wang^3,4，Xianxing Jiang¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Shenzhen Turier Biotech.Co.，Ltd.；State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences&Peking Union Medical College；School of Life Sciences，Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences&Research Unit of Peptide Science，Lanzhou University）.Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs-EBP interaction recover NAFLD through enhancing mitochondrial function in mice[J].Acta Pharmaceutica Sinica B,2023,第2期首页上一页 8 9 10 11 12 下一页尾页共有12页，转到页

期刊文章列表